ADHD affects millions across the lifespan, disrupting school, work and relationships. Once seen as a childhood disorder, it’s ...
Phase 2 randomized, double-blind, placebo-controlled trial planned to evaluate TNX-2900 in children and adolescents (ages 8 to 17.5 years) with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback